Filtros de búsqueda

Lista de obras de Clarisa Beatriz Palatnik-de-Sousa

A Chimera Containing CD4+ and CD8+ T-Cell Epitopes of the Leishmania donovani Nucleoside Hydrolase (NH36) Optimizes Cross-Protection against Leishmania amazonesis Infection.

scientific article published on 23 February 2017

A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN).

artículo científico publicado en 2000

A recombinant vaccine based on domain II of Plasmodium vivax Apical Membrane Antigen 1 induces high antibody titres in mice.

artículo científico publicado en 2010

Acylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis

scientific article published on 02 March 2006

Assessment of the monoterpene, glycidic and triterpene-moieties’ contributions to the adjuvant function of the CP05 saponin of Calliandra pulcherrima Benth during vaccination against experimental visceral leishmaniasis

artículo científico publicado en 2006

Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains

artículo científico publicado en 2014

Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis

artículo científico publicado en 2005

Dependency of B-1 Cells in the Maintenance of Splenic Interleukin-10 Producing Cells and Impairment of Macrophage Resistance in Visceral Leishmaniasis

artículo científico publicado en 2017

Editorial: Epitope Discovery and Synthetic Vaccine Design.

artículo científico publicado en 2018

Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine.

artículo científico publicado en 2004

Expression of leukosialin (CD43) defines a major intrahepatic T cell subset associated with protective responses in visceral leishmaniasis

artículo científico publicado en 2015

F1 Domain of the Leishmania (Leishmania) donovani Nucleoside Hydrolase Promotes a Th1 Response in Leishmania (Leishmania) infantum Cured Patients and in Asymptomatic Individuals Living in an Endemic Area of Leishmaniasis

artículo científico publicado en 2017

Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani

article

IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis

scientific article published on 01 June 2003

Immucillins ImmA and ImmH Are Effective and Non-toxic in the Treatment of Experimental Visceral Leishmaniasis

artículo científico publicado en 2015

Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro

artículo científico publicado en 2015

Immunotherapy against murine experimental visceral leishmaniasis with the FML-vaccine.

artículo científico publicado en 2003

Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani

scientific article published on 20 March 2006

Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis.

artículo científico publicado en 2009

Improving methods for epidemiological control of canine visceral leishmaniasis based on a mathematical model. Impact on the incidence of the canine and human disease

artículo científico publicado en 2004

Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice

artículo científico publicado en 2015

Kinetics and docking studies of two potential new inhibitors of the nucleoside hydrolase from Leishmania donovani.

artículo científico publicado en 2012

Leishmania donovani Nucleoside Hydrolase (NH36) Domains Induce T-Cell Cytokine Responses in Human Visceral Leishmaniasis

artículo científico publicado en 2017

Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the Fucose-Mannose Ligand (FML)

artículo científico publicado en 1993

Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S�o Gon�alo do Amarante, RN)

article

NH36 and F3 Antigen-Primed Dendritic Cells Show Preserved Migrating Capabilities and CCR7 Expression and F3 Is Effective in Immunotherapy of Visceral Leishmaniasis.

artículo científico publicado en 2018

Occurrence of Leishmania donovani parasitemia in plasma of infected hamsters

artículo científico publicado en 2001

One Health: the global challenge of epidemic and endemic leishmaniasis

artículo científico publicado en 2011

Prevalence of Anti-Leishmania donovani Antibody Among Brazilian Blood Donors and Multiply Transfused Hemodialysis Patients ⬇️

artículo científico publicado el 1 de agosto de 1997

Prevalence of IgG Autoantibodies against GD3 Ganglioside in Acute Zika Virus Infection

artículo científico publicado en 2018

Protective vaccination against murine visceral leishmaniasis using aldehyde-containing Quillaja saponaria sapogenins

artículo científico publicado en 2004

Safety trial using the Leishmune vaccine against canine visceral leishmaniasis in Brazil.

artículo científico publicado en 2006

The adjuvanticity of Chiococca alba saponins increases with the length and hydrophilicity of their sugar chains

artículo científico publicado en 2012

Vaccination of Balb/c mice against experimental visceral leishmaniasis with the GP36 glycoprotein antigen of Leishmania donovani

artículo científico publicado en 2001

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani.

artículo científico publicado en 1999

Vaccines for canine leishmaniasis

artículo científico publicado en 2012

Vaccines for leishmaniasis in the fore coming 25 years.

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda